Sinomab Bioscience
Sustainability Report and Carbon Intensity Rankings
Is Sinomab Bioscience doing their part?
Their DitchCarbon score is 42
Sinomab Bioscience has a DitchCarbon Score of 42 out of 100, indicating moderate performance in sustainability practices. This score suggests that the company’s carbon intensity is relatively high, implying there is significant room for improvement in reducing emissions. A higher score would reflect better management of carbon intensity and a stronger commitment to environmental sustainability.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Sinomab Bioscience operates in the industrial manufacturing sector, which has a very low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Unknown
High
Very high
Sinomab Bioscience, located in Washington, operates in a region with an unspecified carbon intensity rating. The sustainability of the company’s operations may be influenced by the local energy grid’s carbon footprint, which is a factor of Washington’s overall carbon intensity.
Unlock 30+ emissions data points on Sinomab Bioscience
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Sinomab Bioscience
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
0.71%
...this company is doing 0.71% better in emissions than the industry average.
Sinomab Bioscience, located on Hong Kong Island, operates within the industrial manufacturing sector. Founded in WA, the company has been a key player since its inception, offering a range of bioscience-related services. They specialize in the development and manufacturing of biochemical products and solutions for various industrial applications.
emission intelligence's platform recommendations for Sinomab Bioscience
Sinomab Bioscience should consider implementing green procurement policies to source low-carbon energy and services, which could potentially reduce their emissions by 30%.
Bad news, Sinomab Bioscience hasn't committed to SBTi goals yet
Sinomab Bioscience has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company has not defined or announced clear goals for reducing greenhouse gas emissions in line with climate science.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.